Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4471772
Max Phase: Preclinical
Molecular Formula: C16H14N2O
Molecular Weight: 250.30
Molecule Type: Unknown
Associated Items:
ID: ALA4471772
Max Phase: Preclinical
Molecular Formula: C16H14N2O
Molecular Weight: 250.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(-n2cnc3c(C)cccc3c2=O)cc1
Standard InChI: InChI=1S/C16H14N2O/c1-11-6-8-13(9-7-11)18-10-17-15-12(2)4-3-5-14(15)16(18)19/h3-10H,1-2H3
Standard InChI Key: FZZSWCOCFKNNQQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 250.30 | Molecular Weight (Monoisotopic): 250.1106 | AlogP: 3.00 | #Rotatable Bonds: 1 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.70 | CX LogP: 3.63 | CX LogD: 3.63 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: -1.29 |
1. Anwar A, Shahbaz MS, Saad SM, Kanwal, Khan KM, Siddiqui R, Khan NA.. (2019) Novel antiacanthamoebic compounds belonging to quinazolinones., 182 [PMID:31415900] [10.1016/j.ejmech.2019.111575] |
Source(1):